Form 8-K - Current report:
SEC Accession No. 0001104659-25-046717
Filing Date
2025-05-09
Accepted
2025-05-09 16:04:15
Documents
16
Period of Report
2025-05-06
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2514338d1_8k.htm   iXBRL 8-K 32322
2 EXHIBIT 3.1 tm2514338d1_ex3-1.htm EX-3.1 11249
3 EXHIBIT 99.1 tm2514338d1_ex99-1.htm EX-99.1 7258
7 GRAPHIC tm2514338d1_ex99-1img01.jpg GRAPHIC 28987
  Complete submission text file 0001104659-25-046717.txt   271847

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rsls-20250506.xsd EX-101.SCH 3047
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rsls-20250506_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rsls-20250506_pre.xml EX-101.PRE 22380
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2514338d1_8k_htm.xml XML 3689
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37897 | Film No.: 25930259
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)